Logo-npj

News and Views

Kidney in chronic uncontrolled hypertension; mind the dual pathology
Dorsa Jahangiri ORCID, Mohammadreza Ardalan* ORCID, Muhammed Mubarak ORCID, Shahrzad Alimohammadi ORCID, Hamid Reza Jahantigh ORCID, Sanam Saeifar ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2022.10507 | Published on: 2022 Sep 18
Edit InpressPDF
Original

Hemodialysis catheter-related bloodstream infections: a single-center experience
Mohan V Bhojaraja ORCID, Ravindra Attur Prabhu* ORCID, Shankar Prasad Nagaraju ORCID, Indu Ramachandra Rao ORCID, Srinivas Vinayak Shenoy ORCID, Dharshan Rangaswamy ORCID, Veena Natti Krishna ORCID, Megha Nagaraj Nayak ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2022.10475 | Published on: 2022 May 31
Edit InpressPDF
Original

Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease–mineral and bone disorder study
Akiko Syawalidhany Tahir* ORCID, Haerani Rasyid ORCID, Syakib Bakri ORCID, Hasyim Kasim ORCID, Tutik Harjianti ORCID, Muhammad Luthfi Parewangi ORCID, Harun Iskandar ORCID, Arifin Seweng ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2022.10446 | Published on: 2022 Apr 24
Edit InpressPDF
Original

Molecular docking study of Momordica charantia Linn phytoconstituent with caspase 3 and implications for renoprotective actions in diabetes mellitus
Mohan Krishna Ghanta ORCID, Swapna R Nayaka ORCID, Poojith Nuthalapati ORCID, AK Afzal Khan ORCID, Panchanathan Elango* ORCID, LVKS Bhaskar* ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2022.10394 | Published on: 2021 Oct 24
Edit InpressPDF
Original

A histopathological study of the effects of ezetimibe and atorvastatin combination against gentamicin-induced kidney injury
Ali Hasanpour Dehkordi ORCID, Banafsheh Yalameha, Aiyoub Pezeshgi* ORCID, Hamid Nasri*, Elham Bijad
J Nephropharmacol. Journal Pre-proof, | Published on: 2021 Feb 28
Edit InpressPDF
Original

Comparative study of nephroprotective effects of resveratrol and silymarin in diabetic rats; an experimental histopathologic study
Elnaz Golestaneh ORCID, Ali Hasanpour Dehkordi, Banafsheh Yalameha, Pegah Noorshargh, Parto Nasri, Hamid Nasri* ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2022.10381 | Published on: 2021 Jan 13
Edit InpressPDF